{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:33:11Z","timestamp":1792146791720,"version":"4.4.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Intramural Research Program of the National Human Genome Research Institute"},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nephropathic cystinosis is a lysosomal storage disease due to biallelic pathogenic variants in the\n                    <jats:italic>CTNS<\/jats:italic>\n                    gene encoding the cystine transport protein cystinosin. Dysfunction of cystinosin results in the intralysosomal accumulation of the disulfide cystine, which crystallizes in some tissues and damages many parenchymal organs. Fanconi syndrome is the first presenting sign with all the features of generalized proximal tubular dysfunction. The natural history of cystinosis includes multisystem complications, the most prominent being glomerular failure at 9\u201310 years. If a kidney transplant prolongs life, other complications occur, with variable frequencies. Some of the most common are hypothyroidism, a distal vacuolar myopathy, pancreatic exocrine and endocrine insufficiency, male hypogonadism, and idiopathic intracranial hypertension. Cystinosis is diagnosed biochemically by measuring the cystine content of leucocyte and molecularly by identifying pathogenic variants in\n                    <jats:italic>CTNS<\/jats:italic>\n                    . Prenatal diagnosis is available. Treatment consists of replacement of kidney tubular losses, symptomatic management of systemic complications, and specific therapy directed at the basic defect, i.e., lysosomal cystine accumulation. This involves the free thiol cysteamine, which can deplete approximately 95% of the lysosomal cystine content. Oral cysteamine therapy has extended the time to kidney failure by approximately 7 years (to a mean of 16 years) and mitigates or prevents late complications of the disease. In addition, cysteamine eyedrops can dissolve corneal cystine crystals within months. Nevertheless, the mean age at death for individuals born between 1985 and 1999 has been 29 years, and earlier diagnosis by newborn screening, treatment with more palatable cystine-depleting agents, and trials with gene therapy are critical current pursuits.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s00467-025-06790-6","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:54:05Z","timestamp":1747230845000},"page":"277-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-term outcomes in nephropathic cystinosis: a review"],"prefix":"10.1007","volume":"41","author":[{"given":"Hayley E.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4539-1504","authenticated-orcid":false,"given":"Mahin S.","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayana","family":"Surampudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Nesterova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"6790_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMra020552","volume":"347","author":"WA Gahl","year":"2002","unstructured":"Gahl WA, Thoene JG, Schneider JA (2002) Cystinosis. N Engl J Med 347:111\u2013121. https:\/\/doi.org\/10.1056\/NEJMra020552","journal-title":"N Engl J Med"},{"key":"6790_CR2","first-page":"5085","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"WA Gahl","year":"2001","unstructured":"Gahl WA, Thoene J, Schneider J (2001) Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp 5085\u20135108"},{"key":"6790_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0006-291x(67)90516-5","volume":"29","author":"JA Schneider","year":"1967","unstructured":"Schneider JA, Rosenbloom FM, Bradley KH, Seegmiller JE (1967) Increased free-cystine content of fibroblasts cultured from patients with cystinosis. Biochem Biophys Res Commun 29:527\u2013531. https:\/\/doi.org\/10.1016\/0006-291x(67)90516-5","journal-title":"Biochem Biophys Res Commun"},{"key":"6790_CR4","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1126\/science.7112129","volume":"217","author":"WA Gahl","year":"1982","unstructured":"Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD (1982) Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 217:1263\u20131265. https:\/\/doi.org\/10.1126\/science.7112129","journal-title":"Science"},{"key":"6790_CR5","first-page":"277","volume":"36","author":"WA Gahl","year":"1984","unstructured":"Gahl WA, Bashan N, Tietze F, Schulman JD (1984) Lysosomal cystine counter-transport in heterozygotes for cystinosis. Am J Hum Genet 36:277\u2013282","journal-title":"Am J Hum Genet"},{"key":"6790_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2215\/CJN.01740407","volume":"3","author":"A Servais","year":"2008","unstructured":"Servais A, Moriniere V, Grunfeld JP, Noel LH, Goujon JM, Chadefaux-Vekemans B, Antignac C (2008) Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping. Clin J Am Soc Nephrol 3:27\u201335. https:\/\/doi.org\/10.2215\/CJN.01740407","journal-title":"Clin J Am Soc Nephrol"},{"key":"6790_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ng0498-319","volume":"18","author":"M Town","year":"1998","unstructured":"Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van\u2019t Hoff W, Antignac C (1998) A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18:319\u2013324. https:\/\/doi.org\/10.1038\/ng0498-319","journal-title":"Nat Genet"},{"key":"6790_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/(SICI)1098-1004(199912)14:6<454::AID-HUMU2>3.0.CO;2-H","volume":"14","author":"Y Anikster","year":"1999","unstructured":"Anikster Y, Shotelersuk V, Gahl WA (1999) CTNS mutations in patients with cystinosis. Hum Mutat 14:454\u2013458. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(199912)14:6%3c454::AID-HUMU2%3e3.0.CO;2-H","journal-title":"Hum Mutat"},{"key":"6790_CR9","volume-title":"GeneReviews\u00ae","author":"G Nesterova","year":"2001","unstructured":"Nesterova G, Gahl WA (2001) Cystinosis. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds) GeneReviews\u00ae. University of Washington, Seattle"},{"key":"6790_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1086\/302118","volume":"63","author":"V Shotelersuk","year":"1998","unstructured":"Shotelersuk V, Larson D, Anikster Y, McDowell G, Lemons R, Bernardini I, Guo J, Thoene J, Gahl WA (1998) CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet 63:1352\u20131362. https:\/\/doi.org\/10.1086\/302118","journal-title":"Am J Hum Genet"},{"key":"6790_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1006\/mgme.1999.2876","volume":"67","author":"J Thoene","year":"1999","unstructured":"Thoene J, Lemons R, Anikster Y, Mullet J, Paelicke K, Lucero C, Gahl W, Schneider J, Shu SG, Campbell HT (1999) Mutations of CTNS causing intermediate cystinosis. Mol Genet Metab 67:283\u2013293. https:\/\/doi.org\/10.1006\/mgme.1999.2876","journal-title":"Mol Genet Metab"},{"key":"6790_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1203\/00006450-200001000-00007","volume":"47","author":"Y Anikster","year":"2000","unstructured":"Anikster Y, Lucero C, Guo J, Huizing M, Shotelersuk V, Bernardini I, McDowell G, Iwata F, Kaiser-Kupfer MI, Jaffe R, Thoene J, Schneider JA, Gahl WA (2000) Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations. Pediatr Res 47:17\u201323. https:\/\/doi.org\/10.1203\/00006450-200001000-00007","journal-title":"Pediatr Res"},{"key":"6790_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0065-3101(24)00302-5","volume":"33","author":"WA Gahl","year":"1986","unstructured":"Gahl WA (1986) Cystinosis coming of age. Adv Pediatr 33:95\u2013126","journal-title":"Adv Pediatr"},{"key":"6790_CR14","first-page":"582","volume":"19","author":"N Gretz","year":"1983","unstructured":"Gretz N, Manz F, Augustin R, Barrat TM, Bender-Gotze C, Brandis M, Bremer HJ, Brodehl J, Broyer M, Bulla M, Callis L, Chantler C, Diekmann L, Dillon MJ, Egli F, Ehrich JH, Endres W, Fanconi A, Feldhoff C, Geisert J, Gekle D, Gescholl-Bauer B, Grote K, Gruttner R, Hagge W, Haycock CB, Hennemann H, Klare B, Leupold D, Lohr H, Michalk D, Oliveira A, Ott F, Pistor K, Rau J, Scharer K, Schindera F, Schmidt H, Schulte-Wissermann H, Verrier-Jones K, Weber HP, Willenbockel U, Wolf H (1983) Survival time in cystinosis. A collaborative study. Proc Eur Dial Transplant Assoc 19:582\u2013589","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"6790_CR15","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.kint.2020.07.012","volume":"98","author":"J Malyszko","year":"2020","unstructured":"Malyszko J, Bamias A, Danesh FR, Debska-Slizien A, Gallieni M, Gertz MA, Kielstein JT, Tesarova P, Wong G, Cheung M, Wheeler DC, Winkelmayer WC, Porta C, Conference P (2020) KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation. Kidney Int 98:1407\u20131418. https:\/\/doi.org\/10.1016\/j.kint.2020.07.012","journal-title":"Kidney Int"},{"key":"6790_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1042\/bj2280545","volume":"228","author":"WA Gahl","year":"1985","unstructured":"Gahl WA, Tietze F, Butler JD, Schulman JD (1985) Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. Biochem J 228:545\u2013550. https:\/\/doi.org\/10.1042\/bj2280545","journal-title":"Biochem J"},{"key":"6790_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1172\/JCI108448","volume":"58","author":"JG Thoene","year":"1976","unstructured":"Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider JA (1976) Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest 58:180\u2013189. https:\/\/doi.org\/10.1172\/JCI108448","journal-title":"J Clin Invest"},{"key":"6790_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJM198704163161602","volume":"316","author":"WA Gahl","year":"1987","unstructured":"Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesselman JJ, Corden BJ, Schneider JA (1987) Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316:971\u2013977. https:\/\/doi.org\/10.1056\/NEJM198704163161602","journal-title":"N Engl J Med"},{"key":"6790_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s0022-3476(05)82072-4","volume":"119","author":"VM Reznik","year":"1991","unstructured":"Reznik VM, Adamson M, Adelman RD, Murphy JL, Gahl WA, Clark KF, Schneider JA (1991) Treatment of cystinosis with cysteamine from early infancy. J Pediatr 119:491\u2013493. https:\/\/doi.org\/10.1016\/s0022-3476(05)82072-4","journal-title":"J Pediatr"},{"key":"6790_CR20","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJM199304223281604","volume":"328","author":"TC Markello","year":"1993","unstructured":"Markello TC, Bernardini IM, Gahl WA (1993) Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328:1157\u20131162. https:\/\/doi.org\/10.1056\/NEJM199304223281604","journal-title":"N Engl J Med"},{"key":"6790_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJM198703263161304","volume":"316","author":"MI Kaiser-Kupfer","year":"1987","unstructured":"Kaiser-Kupfer MI, Fujikawa L, Kuwabara T, Jain S, Gahl WA (1987) Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med 316:775\u2013779. https:\/\/doi.org\/10.1056\/NEJM198703263161304","journal-title":"N Engl J Med"},{"key":"6790_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1001\/archopht.1990.01070070075038","volume":"108","author":"MI Kaiser-Kupfer","year":"1990","unstructured":"Kaiser-Kupfer MI, Gazzo MA, Datiles MB, Caruso RC, Kuehl EM, Gahl WA (1990) A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. Arch Ophthalmol 108:689\u2013693. https:\/\/doi.org\/10.1001\/archopht.1990.01070070075038","journal-title":"Arch Ophthalmol"},{"key":"6790_CR23","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1056\/NEJM198812013192206","volume":"319","author":"WA Gahl","year":"1988","unstructured":"Gahl WA, Dalakas MC, Charnas L, Chen KT, Pezeshkpour GH, Kuwabara T, Davis SL, Chesney RW, Fink J, Hutchison HT (1988) Myopathy and cystine storage in muscles in a patient with nephropathic cystinosis. N Engl J Med 319:1461\u20131464. https:\/\/doi.org\/10.1056\/NEJM198812013192206","journal-title":"N Engl J Med"},{"key":"6790_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.410350209","volume":"35","author":"LR Charnas","year":"1994","unstructured":"Charnas LR, Luciano CA, Dalakas M, Gilliatt RW, Bernardini I, Ishak K, Cwik VA, Fraker D, Brushart TA, Gahl WA (1994) Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol 35:181\u2013188. https:\/\/doi.org\/10.1002\/ana.410350209","journal-title":"Ann Neurol"},{"key":"6790_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1056\/NEJM199008303230903","volume":"323","author":"BC Sonies","year":"1990","unstructured":"Sonies BC, Ekman EF, Andersson HC, Adamson MD, Kaler SG, Markello TC, Gahl WA (1990) Swallowing dysfunction in nephropathic cystinosis. N Engl J Med 323:565\u2013570. https:\/\/doi.org\/10.1056\/NEJM199008303230903","journal-title":"N Engl J Med"},{"key":"6790_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/01.md.0000164204.00159.d4","volume":"84","author":"BC Sonies","year":"2005","unstructured":"Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA (2005) Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Medicine (Baltimore) 84:137\u2013146. https:\/\/doi.org\/10.1097\/01.md.0000164204.00159.d4","journal-title":"Medicine (Baltimore)"},{"key":"6790_CR27","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/archpedi.1987.04460100065027","volume":"141","author":"B Fivush","year":"1987","unstructured":"Fivush B, Green OC, Porter CC, Balfe JW, O\u2019Regan S, Gahl WA (1987) Pancreatic endocrine insufficiency in posttransplant cystinosis. Am J Dis Child 141:1087\u20131089. https:\/\/doi.org\/10.1001\/archpedi.1987.04460100065027","journal-title":"Am J Dis Child"},{"key":"6790_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archneur.1989.00520410077027","volume":"46","author":"JK Fink","year":"1989","unstructured":"Fink JK, Brouwers P, Barton N, Malekzadeh MH, Sato S, Hill S, Cohen WE, Fivush B, Gahl WA (1989) Neurologic complications in long-standing nephropathic cystinosis. Arch Neurol 46:543\u2013548. https:\/\/doi.org\/10.1001\/archneur.1989.00520410077027","journal-title":"Arch Neurol"},{"key":"6790_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/s0022-3476(84)80494-1","volume":"104","author":"WA Gahl","year":"1984","unstructured":"Gahl WA, Hubbard VS, Orloff S (1984) Decreased sweat production in cystinosis. J Pediatr 104:904\u2013905. https:\/\/doi.org\/10.1016\/s0022-3476(84)80494-1","journal-title":"J Pediatr"},{"key":"6790_CR30","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/archopht.1986.01050170096030","volume":"104","author":"MI Kaiser-Kupfer","year":"1986","unstructured":"Kaiser-Kupfer MI, Caruso RC, Minkler DS, Gahl WA (1986) Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol 104:706\u2013711. https:\/\/doi.org\/10.1001\/archopht.1986.01050170096030","journal-title":"Arch Ophthalmol"},{"key":"6790_CR31","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jpeds.2004.06.080","volume":"145","author":"CF Dogulu","year":"2004","unstructured":"Dogulu CF, Tsilou E, Rubin B, Fitzgibbon EJ, Kaiser-Kupper MI, Rennert OM, Gahl WA (2004) Idiopathic intracranial hypertension in cystinosis. J Pediatr 145:673\u2013678. https:\/\/doi.org\/10.1016\/j.jpeds.2004.06.080","journal-title":"J Pediatr"},{"key":"6790_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2215\/CJN.01431005","volume":"1","author":"M Ueda","year":"2006","unstructured":"Ueda M, O\u2019Brien K, Rosing DR, Ling A, Kleta R, McAreavey D, Bernardini I, Gahl WA (2006) Coronary artery and other vascular calcifications in patients with cystinosis after kidney transplantation. Clin J Am Soc Nephrol 1:555\u2013562. https:\/\/doi.org\/10.2215\/CJN.01431005","journal-title":"Clin J Am Soc Nephrol"},{"key":"6790_CR33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.7326\/0003-4819-119-7_part_1-199310010-00004","volume":"119","author":"CL Chik","year":"1993","unstructured":"Chik CL, Friedman A, Merriam GR, Gahl WA (1993) Pituitary-testicular function in nephropathic cystinosis. Ann Intern Med 119:568\u2013575. https:\/\/doi.org\/10.7326\/0003-4819-119-7_part_1-199310010-00004","journal-title":"Ann Intern Med"},{"key":"6790_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1056\/NEJM198807283190406","volume":"319","author":"RE Reiss","year":"1988","unstructured":"Reiss RE, Kuwabara T, Smith ML, Gahl WA (1988) Successful pregnancy despite placental cystine crystals in a woman with nephropathic cystinosis. N Engl J Med 319:223\u2013226. https:\/\/doi.org\/10.1056\/NEJM198807283190406","journal-title":"N Engl J Med"},{"key":"6790_CR35","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00467-007-0650-8","volume":"23","author":"G Nesterova","year":"2008","unstructured":"Nesterova G, Gahl W (2008) Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol 23:863\u2013878. https:\/\/doi.org\/10.1007\/s00467-007-0650-8","journal-title":"Pediatr Nephrol"},{"key":"6790_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgae502","volume":"00","author":"J Lahring","year":"2024","unstructured":"Lahring J, Leifheit-Nestler M, Ewert A, Herzig N, Koppl C, Pott V, Oh J, Buscher A, Thumfart J, Weber LT, Arbeiter K, Acham-Roschitz B, Tonshoff B, Zivicnjak M, Hohenfellner K, Haffner D (2024) Cystinosis-associated metabolic bone disease across ages and CKD stages 1\u20135D\/T. J Clin Endocrinol Metab 00:1\u201313. https:\/\/doi.org\/10.1210\/clinem\/dgae502","journal-title":"J Clin Endocrinol Metab"},{"key":"6790_CR37","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/jbmr.3522","volume":"33","author":"P Florenzano","year":"2018","unstructured":"Florenzano P, Ferreira C, Nesterova G, Roberts MS, Tella SH, de Castro LF, Brown SM, Whitaker A, Pereira RC, Bulas D, Gafni RI, Salusky IB, Gahl WA, Collins MT (2018) Skeletal consequences of nephropathic cystinosis. J Bone Miner Res 33:1870\u20131880. https:\/\/doi.org\/10.1002\/jbmr.3522","journal-title":"J Bone Miner Res"},{"key":"6790_CR38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00467-018-3902-x","volume":"33","author":"A Bertholet-Thomas","year":"2018","unstructured":"Bertholet-Thomas A, Claramunt-Taberner D, Gaillard S, Deschenes G, Sornay-Rendu E, Szulc P, Cohen-Solal M, Pelletier S, Carlier MC, Cochat P, Bacchetta J (2018) Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairment. Pediatr Nephrol 33:1165\u20131172. https:\/\/doi.org\/10.1007\/s00467-018-3902-x","journal-title":"Pediatr Nephrol"},{"key":"6790_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/8904_2013_256","volume":"13","author":"S Sirrs","year":"2014","unstructured":"Sirrs S, Munk P, Mallinson PI, Ouellette H, Horvath G, Cooper S, Da Roza G, Rosenbaum D, O\u2019Riley M, Nussbaumer G, Hoang LN, Lee CH (2014) Cystinosis with sclerotic bone lesions. JIMD Rep 13:27\u201331. https:\/\/doi.org\/10.1007\/8904_2013_256","journal-title":"JIMD Rep"},{"key":"6790_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00467-012-2242-5","volume":"28","author":"G Nesterova","year":"2013","unstructured":"Nesterova G, Gahl WA (2013) Cystinosis: the evolution of a treatable disease. Pediatr Nephrol 28:51\u201359. https:\/\/doi.org\/10.1007\/s00467-012-2242-5","journal-title":"Pediatr Nephrol"},{"key":"6790_CR41","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/jcsm.13579","volume":"15","author":"WW Cheung","year":"2024","unstructured":"Cheung WW, Zhou P, Zheng R, Gertler A, Oliveira EA, Mak RH (2024) Leptin signalling altered in infantile nephropathic cystinosis-related bone disorder. J Cachexia Sarcopenia Muscle 15:2447\u20132459. https:\/\/doi.org\/10.1002\/jcsm.13579","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"6790_CR42","doi-asserted-by":"publisher","unstructured":"Ewert A, Leifheit-Nestler M, Hohenfellner K, Buscher A, Kemper MJ, Oh J, Billing H, Thumfart J, Stangl G, Baur AC, Foller M, Feger M, Weber LT, Acham-Roschitz B, Arbeiter K, Tonshoff B, Zivicnjak M, Haffner D (2020) Bone and mineral metabolism in children with nephropathic cystinosis compared with other CKD entities. J Clin Endocrinol Metab 105. https:\/\/doi.org\/10.1210\/clinem\/dgaa267","DOI":"10.1210\/clinem\/dgaa267"},{"key":"6790_CR43","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1681\/ASN.2019111172","volume":"31","author":"P Florenzano","year":"2020","unstructured":"Florenzano P, Jimenez M, Ferreira CR, Nesterova G, Roberts MS, Tella SH, Fernandez de Castro L, Gafni RI, Wolf M, Juppner H, Gales B, Wesseling-Perry K, Markovich D, Gahl WA, Salusky IB, Collins MT (2020) Nephropathic cystinosis: a distinct form of CKD-mineral and bone disorder that provides novel insights into the regulation of FGF23. J Am Soc Nephrol 31:2184\u20132192. https:\/\/doi.org\/10.1681\/ASN.2019111172","journal-title":"J Am Soc Nephrol"},{"key":"6790_CR44","doi-asserted-by":"publisher","unstructured":"Hohenfellner K, Rauch F, Ariceta G, Awan A, Bacchetta J, Bergmann C, Bechtold S, Cassidy N, Deschenes G, Elenberg E, Gahl WA, Greil O, Harms E, Herzig N, Hoppe B, Koeppl C, Lewis MA, Levtchenko E, Nesterova G, Santos F, Schlingmann KP, Servais A, Soliman NA, Steidle G, Sweeney C, Treikauskas U, Topaloglu R, Tsygin A, Veys K, R VV, Zustin J, Haffner D (2019) Management of bone disease in cystinosis: statement from an international conference. J Inherit Metab Dis 42:1019-1029. https:\/\/doi.org\/10.1002\/jimd.12134","DOI":"10.1002\/jimd.12134"},{"key":"6790_CR45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/MOP.0000000000000462","volume":"29","author":"KR Veys","year":"2017","unstructured":"Veys KR, Elmonem MA, Arcolino FO, van den Heuvel L, Levtchenko E (2017) Nephropathic cystinosis: an update. Curr Opin Pediatr 29:168\u2013178. https:\/\/doi.org\/10.1097\/MOP.0000000000000462","journal-title":"Curr Opin Pediatr"},{"key":"6790_CR46","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/jimd.12473","volume":"45","author":"R Kluck","year":"2022","unstructured":"Kluck R, Muller S, Jagodzinski C, Hohenfellner K, Buscher A, Kemper MJ, Oh J, Billing H, Thumfart J, Weber LT, Acham-Roschitz B, Arbeiter K, Tonshoff B, Hagenberg M, Kanzelmeyer N, Pavicic L, Haffner D, Zivicnjak M (2022) Body growth, upper arm fat area, and clinical parameters in children with nephropathic cystinosis compared with other pediatric chronic kidney disease entities. J Inherit Metab Dis 45:192\u2013202. https:\/\/doi.org\/10.1002\/jimd.12473","journal-title":"J Inherit Metab Dis"},{"key":"6790_CR47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jpeds.2004.03.056","volume":"145","author":"R Kleta","year":"2004","unstructured":"Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA (2004) Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr 145:555\u2013560","journal-title":"J Pediatr"},{"key":"6790_CR48","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1067\/mpd.2001.113263","volume":"138","author":"E Wuhl","year":"2001","unstructured":"W\u00fchl E, Haffner D, Offner G, Broyer M, van\u2019t Hoff W, Mehls O; European Study Group on Growth Hormone Treatment in Children with Nephropathic Cystinosis (2001) Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr 138:880\u2013887. https:\/\/doi.org\/10.1067\/mpd.2001.113263","journal-title":"J Pediatr"},{"key":"6790_CR49","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s00467-012-2213-x","volume":"27","author":"MTP Besouw","year":"2012","unstructured":"Besouw MTP, Van Dyck M, Francois I, Van Hoyweghen E, Levtchenko EN (2012) Detailed studies of growth hormone secretion in cystinosis patients. Pediatr Nephrol 27:2123\u20132127. https:\/\/doi.org\/10.1007\/s00467-012-2213-x","journal-title":"Pediatr Nephrol"},{"key":"6790_CR50","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jpeds.2016.12.049","volume":"183S","author":"E Levtchenko","year":"2017","unstructured":"Levtchenko E (2017) Endocrine complications of cystinosis. J Pediatr 183S:S5\u2013S8. https:\/\/doi.org\/10.1016\/j.jpeds.2016.12.049","journal-title":"J Pediatr"},{"issue":"Suppl 4","key":"6790_CR51","doi-asserted-by":"publisher","first-page":"iv87","DOI":"10.1093\/ndt\/gfu090","volume":"29","author":"F Emma","year":"2014","unstructured":"Emma F, Nesterova G, Langman C, Labbe A, Cherqui S, Goodyer P, Janssen MC, Greco M, Topaloglu R, Elenberg E, Dohil R, Trauner D, Antignac C, Cochat P, Kaskel F, Servais A, Wuhl E, Niaudet P, Van\u2019t Hoff W, Gahl W, Levtchenko E (2014) Nephropathic cystinosis: an international consensus document. Nephrol Dial Transplant 29(Suppl 4):iv87-94. https:\/\/doi.org\/10.1093\/ndt\/gfu090","journal-title":"Nephrol Dial Transplant"},{"key":"6790_CR52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1601-0825.2010.01662.x","volume":"16","author":"CW Bassim","year":"2010","unstructured":"Bassim CW, Gautam P, Domingo DL, Balog JZ, Guadagnini JP, Gahl WA, Hart TC (2010) Craniofacial and dental findings in cystinosis. Oral Dis 16:488\u2013495. https:\/\/doi.org\/10.1111\/j.1601-0825.2010.01662.x","journal-title":"Oral Dis"},{"key":"6790_CR53","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1210\/jcem.80.11.7593434","volume":"80","author":"VE Kimonis","year":"1995","unstructured":"Kimonis VE, Troendle J, Rose SR, Yang ML, Markello TC, Gahl WA (1995) Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab 80:3257\u20133261. https:\/\/doi.org\/10.1210\/jcem.80.11.7593434","journal-title":"J Clin Endocrinol Metab"},{"key":"6790_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.7326\/0003-4819-147-4-200708210-00006","volume":"147","author":"WA Gahl","year":"2007","unstructured":"Gahl WA, Balog JZ, Kleta R (2007) Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intern Med 147:242\u2013250. https:\/\/doi.org\/10.7326\/0003-4819-147-4-200708210-00006","journal-title":"Ann Intern Med"},{"key":"6790_CR55","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s004310050926","volume":"157","author":"G Filler","year":"1998","unstructured":"Filler G, Amendt P, von Bredow MA, Rohde W, Ehrich JH (1998) Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis. Eur J Pediatr 157:738\u2013742. https:\/\/doi.org\/10.1007\/s004310050926","journal-title":"Eur J Pediatr"},{"key":"6790_CR56","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s004670050651","volume":"13","author":"JJ Robert","year":"1999","unstructured":"Robert JJ, Tete MJ, Guest G, Gagnadoux MF, Niaudet P, Broyer M (1999) Diabetes mellitus in patients with infantile cystinosis after renal transplantation. Pediatr Nephrol 13:524\u2013529. https:\/\/doi.org\/10.1007\/s004670050651","journal-title":"Pediatr Nephrol"},{"key":"6790_CR57","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/humrep\/deab030","volume":"36","author":"J Rohayem","year":"2021","unstructured":"Rohayem J, Haffner D, Cremers JF, Huss S, Wistuba J, Weitzel D, Kliesch S, Hohenfellner K (2021) Testicular function in males with infantile nephropathic cystinosis. Hum Reprod 36:1191\u20131204. https:\/\/doi.org\/10.1093\/humrep\/deab030","journal-title":"Hum Reprod"},{"key":"6790_CR58","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00467-015-3117-3","volume":"30","author":"MT Besouw","year":"2015","unstructured":"Besouw MT, Van Dyck M, Cassiman D, Claes KJ, Levtchenko EN (2015) Management dilemmas in pediatric nephrology: cystinosis. Pediatr Nephrol 30:1349\u20131360. https:\/\/doi.org\/10.1007\/s00467-015-3117-3","journal-title":"Pediatr Nephrol"},{"key":"6790_CR59","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/BF01956154","volume":"152","author":"L Winkler","year":"1993","unstructured":"Winkler L, Offner G, Krull F, Brodehl J (1993) Growth and pubertal development in nephropathic cystinosis. Eur J Pediatr 152:244\u2013249. https:\/\/doi.org\/10.1007\/BF01956154","journal-title":"Eur J Pediatr"},{"key":"6790_CR60","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/jimd.12434","volume":"44","author":"A Reda","year":"2021","unstructured":"Reda A, Veys K, Kadam P, Taranta A, Rega LR, Goffredo BM, Camps C, Besouw M, Cyr D, Albersen M, Spiessens C, de Wever L, Hamer R, Janssen MCH, D\u2019Hauwers K, Wetzels A, Monnens L, van den Heuvel L, Goossens E, Levtchenko E (2021) Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood-testis barrier and a subtherapeutic effect of cysteamine in testis. J Inherit Metab Dis 44:1393\u20131408. https:\/\/doi.org\/10.1002\/jimd.12434","journal-title":"J Inherit Metab Dis"},{"key":"6790_CR61","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.fertnstert.2012.03.050","volume":"98","author":"MT Besouw","year":"2012","unstructured":"Besouw MT, van Pelt AM, Gaide Chevronnay HP, Courtoy PJ, Pastore A, Goossens E, Devuyst O, Antignac C, Levtchenko EN (2012) Studying nonobstructive azoospermia in cystinosis: histologic examination of testes and epididymis and sperm analysis in a Ctns(-)\/(-) mouse model. Fertil Steril 98:162\u2013165. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.03.050","journal-title":"Fertil Steril"},{"key":"6790_CR62","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ekir.2023.10.030","volume":"9","author":"CB Langman","year":"2024","unstructured":"Langman CB, Delos Santos RB, Ghossein C, Atherton AM, Levtchenko EN, Servais A (2024) Fertility management in cystinosis: a clinical perspective. Kidney Int Rep 9:214\u2013224. https:\/\/doi.org\/10.1016\/j.ekir.2023.10.030","journal-title":"Kidney Int Rep"},{"key":"6790_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/8904_2017_19","volume":"38","author":"KR Veys","year":"2018","unstructured":"Veys KR, D\u2019Hauwers KW, van Dongen A, Janssen MC, Besouw MTP, Goossens E, van den Heuvel LP, Wetzels A, Levtchenko EN (2018) First successful conception induced by a male cystinosis patient. JIMD Rep 38:1\u20136. https:\/\/doi.org\/10.1007\/8904_2017_19","journal-title":"JIMD Rep"},{"key":"6790_CR64","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/jimd.12529","volume":"45","author":"A Servais","year":"2022","unstructured":"Servais A, Janssen MCH, Blakey H, Greco M, Lemoine S, Martin-Moreno PL, Game D, Levtchenko E, Lipkin G; Metabolic Nephropathy Workgroup of the European Reference Network for Rare Kidney Diseases (ERKNet) and the ERA working groups on inherited kidney diseases (WGIKD) (2022) Pregnancy in cystinosis patients with chronic kidney disease: a European case series. J Inherit Metab Dis 45:963\u2013968. https:\/\/doi.org\/10.1002\/jimd.12529","journal-title":"J Inherit Metab Dis"},{"key":"6790_CR65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/mgme.2000.3062","volume":"71","author":"WA Gahl","year":"2000","unstructured":"Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI (2000) Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab 71:100\u2013120. https:\/\/doi.org\/10.1006\/mgme.2000.3062","journal-title":"Mol Genet Metab"},{"key":"6790_CR66","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/archopht.1967.00980020363014","volume":"77","author":"VG Wong","year":"1967","unstructured":"Wong VG, Lietman PS, Seegmiller JE (1967) Alterations of pigment epithelium in cystinosis. Arch Ophthalmol 77:361\u2013369. https:\/\/doi.org\/10.1001\/archopht.1967.00980020363014","journal-title":"Arch Ophthalmol"},{"key":"6790_CR67","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3928\/0191-3913-20030501-07","volume":"40","author":"P Dureau","year":"2003","unstructured":"Dureau P, Broyer M, Dufier JL (2003) Evolution of ocular manifestations in nephropathic cystinosis: a long-term study of a population treated with cysteamine. J Pediatr Ophthalmol Strabismus 40:142\u2013146. https:\/\/doi.org\/10.3928\/0191-3913-20030501-07","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"6790_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00003226-200203000-00009","volume":"21","author":"ET Tsilou","year":"2002","unstructured":"Tsilou ET, Rubin BI, Reed GF, Iwata F, Gahl W, Kaiser-Kupfer MI (2002) Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis. Cornea 21:173\u2013176. https:\/\/doi.org\/10.1097\/00003226-200203000-00009","journal-title":"Cornea"},{"key":"6790_CR69","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ophtha.2005.12.026","volume":"113","author":"ET Tsilou","year":"2006","unstructured":"Tsilou ET, Rubin BI, Reed G, Caruso RC, Iwata F, Balog J, Gahl WA, Kaiser-Kupfer MI (2006) Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy. Ophthalmology 113:1002\u20131009. https:\/\/doi.org\/10.1016\/j.ophtha.2005.12.026","journal-title":"Ophthalmology"},{"key":"6790_CR70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12886-020-01336-w","volume":"20","author":"A Csorba","year":"2020","unstructured":"Csorba A, Maka E, Maneschg OA, Szabo A, Szentmary N, Csidey M, Resch M, Imre L, Knezy K, Nagy ZZ (2020) Examination of corneal deposits in nephropathic cystinosis using in vivo confocal microscopy and anterior segment optical coherence tomography: an age-dependent cross sectional study. BMC Ophthalmol 20:73. https:\/\/doi.org\/10.1186\/s12886-020-01336-w","journal-title":"BMC Ophthalmol"},{"key":"6790_CR71","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00467-023-06211-6","volume":"39","author":"MW Joseph","year":"2024","unstructured":"Joseph MW, Stein DR, Stein AC (2024) Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives. Pediatr Nephrol 39:2845\u20132860. https:\/\/doi.org\/10.1007\/s00467-023-06211-6","journal-title":"Pediatr Nephrol"},{"key":"6790_CR72","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s004670050467","volume":"12","author":"E Elenberg","year":"1998","unstructured":"Elenberg E, Norling LL, Kleinman RE, Ingelfinger JR (1998) Feeding problems in cystinosis. Pediatr Nephrol 12:365\u2013370. https:\/\/doi.org\/10.1007\/s004670050467","journal-title":"Pediatr Nephrol"},{"key":"6790_CR73","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12876-020-01385-x","volume":"20","author":"R Topaloglu","year":"2020","unstructured":"Topaloglu R, Gultekingil A, Gulhan B, Ozaltin F, Demir H, Ciftci T, Demir N, Temucin CM, Yuce A, Akhan O (2020) Cystinosis beyond kidneys: gastrointestinal system and muscle involvement. BMC Gastroenterol 20:242. https:\/\/doi.org\/10.1186\/s12876-020-01385-x","journal-title":"BMC Gastroenterol"},{"key":"6790_CR74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1067\/S0022-3476(03)00281-6","volume":"143","author":"R Dohil","year":"2003","unstructured":"Dohil R, Newbury RO, Sellers ZM, Deutsch R, Schneider JA (2003) The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine. J Pediatr 143:224\u2013230. https:\/\/doi.org\/10.1067\/S0022-3476(03)00281-6","journal-title":"J Pediatr"},{"key":"6790_CR75","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jpeds.2012.03.011","volume":"161","author":"R Dohil","year":"2012","unstructured":"Dohil R, Carrigg A, Newbury R (2012) A potential new method to estimate tissue cystine content in nephropathic cystinosis. J Pediatr 161:531\u2013535. https:\/\/doi.org\/10.1016\/j.jpeds.2012.03.011","journal-title":"J Pediatr"},{"key":"6790_CR76","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s004670000318","volume":"14","author":"JE Coleman","year":"2000","unstructured":"Coleman JE, Watson AR (2000) Gastrostomy buttons for nutritional support in children with cystinosis. Pediatr Nephrol 14:833\u2013836. https:\/\/doi.org\/10.1007\/s004670000318","journal-title":"Pediatr Nephrol"},{"key":"6790_CR77","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/s0022-3476(86)80221-9","volume":"109","author":"WA Gahl","year":"1986","unstructured":"Gahl WA, Schneider JA, Thoene JG, Chesney R (1986) Course of nephropathic cystinosis after age 10 years. J Pediatr 109:605\u2013608. https:\/\/doi.org\/10.1016\/s0022-3476(86)80221-9","journal-title":"J Pediatr"},{"key":"6790_CR78","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1111\/j.1440-1746.2008.05312.x","volume":"23","author":"T Cornelis","year":"2008","unstructured":"Cornelis T, Claes K, Gillard P, Nijs E, Roskams T, Lombaerts R, Nevens F, Cassiman D (2008) Cholestatic liver disease in long-term infantile nephropathic cystinosis. J Gastroenterol Hepatol 23:e428\u2013e431. https:\/\/doi.org\/10.1111\/j.1440-1746.2008.05312.x","journal-title":"J Gastroenterol Hepatol"},{"key":"6790_CR79","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s10620-005-2789-0","volume":"50","author":"S Rossi","year":"2005","unstructured":"Rossi S, Herrine SK, Navarro VJ (2005) Cystinosis as a cause of noncirrhotic portal hypertension. Dig Dis Sci 50:1372\u20131375. https:\/\/doi.org\/10.1007\/s10620-005-2789-0","journal-title":"Dig Dis Sci"},{"key":"6790_CR80","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000134222","volume":"119","author":"A Emadi","year":"2008","unstructured":"Emadi A, Burns KH, Confer B, Borowitz MJ, Streiff MB (2008) Hematological manifestations of nephropathic cystinosis. Acta Haematol 119:169\u2013172. https:\/\/doi.org\/10.1159\/000134222","journal-title":"Acta Haematol"},{"key":"6790_CR81","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cgh.2005.12.013","volume":"4","author":"K O\u2019Brien","year":"2006","unstructured":"O\u2019Brien K, Hussain N, Warady BA, Kleiner DE, Kleta R, Bernardini I, Heller T, Gahl WA (2006) Nodular regenerative hyperplasia and severe portal hypertension in cystinosis. Clin Gastroenterol Hepatol 4:387\u2013394. https:\/\/doi.org\/10.1016\/j.cgh.2005.12.013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6790_CR82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ajh.20040","volume":"76","author":"JP Quinn","year":"2004","unstructured":"Quinn JP, Royston D, Murphy PT (2004) Bone marrow findings in hereditary cystinosis with renal failure. Am J Hematol 76:79. https:\/\/doi.org\/10.1002\/ajh.20040","journal-title":"Am J Hematol"},{"key":"6790_CR83","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/mus.26726","volume":"61","author":"R Sadjadi","year":"2020","unstructured":"Sadjadi R, Sullivan S, Grant N, Thomas SE, Doyle M, Hammond C, Duong R, Corre C, David W, Eichler F (2020) Clinical myopathy in patients with nephropathic cystinosis. Muscle Nerve 61:74\u201380. https:\/\/doi.org\/10.1002\/mus.26726","journal-title":"Muscle Nerve"},{"key":"6790_CR84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s004670050009","volume":"14","author":"U Vester","year":"2000","unstructured":"Vester U, Schubert M, Offner G, Brodehl J (2000) Distal myopathy in nephropathic cystinosis. Pediatr Nephrol 14:36\u201338. https:\/\/doi.org\/10.1007\/s004670050009","journal-title":"Pediatr Nephrol"},{"key":"6790_CR85","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ekir.2020.11.017","volume":"6","author":"H Iyob-Tessema","year":"2021","unstructured":"Iyob-Tessema H, Wang CS, Kennedy S, Reyes L, Shin S, Greenbaum LA, Hogan J (2021) Grip strength in adults and children with cystinosis. Kidney Int Rep 6:389\u2013395. https:\/\/doi.org\/10.1016\/j.ekir.2020.11.017","journal-title":"Kidney Int Rep"},{"key":"6790_CR86","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jimd.12464","volume":"45","author":"K Vill","year":"2022","unstructured":"Vill K, Muller-Felber W, Landfarth T, Koppl C, Herzig N, Knerr C, Holla H, Steidle G, Harms E, Hohenfellner K, Interdisciplinary Cystinosis Group (2022) Neuromuscular conditions and the impact of cystine-depleting therapy in infantile nephropathic cystinosis: a cross-sectional analysis of 55 patients. J Inherit Metab Dis 45:183\u2013191. https:\/\/doi.org\/10.1002\/jimd.12464","journal-title":"J Inherit Metab Dis"},{"key":"6790_CR87","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/s0887-8994(01)00268-5","volume":"24","author":"DA Trauner","year":"2001","unstructured":"Trauner DA, Fahmy RF, Mishler DA (2001) Oral motor dysfunction and feeding difficulties in nephropathic cystinosis. Pediatr Neurol 24:365\u2013368. https:\/\/doi.org\/10.1016\/s0887-8994(01)00268-5","journal-title":"Pediatr Neurol"},{"key":"6790_CR88","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ymgme.2019.01.011","volume":"126","author":"AE van Rijssel","year":"2019","unstructured":"van Rijssel AE, Knuijt S, Veys K, Levtchenko EN, Janssen MCH (2019) Swallowing dysfunction in patients with nephropathic cystinosis. Mol Genet Metab 126:413\u2013415. https:\/\/doi.org\/10.1016\/j.ymgme.2019.01.011","journal-title":"Mol Genet Metab"},{"key":"6790_CR89","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1378\/chest.119.2.394","volume":"119","author":"Y Anikster","year":"2001","unstructured":"Anikster Y, Lacbawan F, Brantly M, Gochuico BL, Avila NA, Travis W, Gahl WA (2001) Pulmonary dysfunction in adults with nephropathic cystinosis. Chest 119:394\u2013401. https:\/\/doi.org\/10.1378\/chest.119.2.394","journal-title":"Chest"},{"key":"6790_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43054-022-00098-y","volume":"70","author":"DH Hamed","year":"2022","unstructured":"Hamed DH, Halim RMA, El Attar MM et al (2022) Pulmonary dysfunction in children with cystinosis: single center study. Egypt Pediatr Assoc Gaz 70:1\u20137. https:\/\/doi.org\/10.1186\/s43054-022-00098-y","journal-title":"Egypt Pediatr Assoc Gaz"},{"key":"6790_CR91","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/ckj\/sfac099","volume":"15","author":"E Levtchenko","year":"2022","unstructured":"Levtchenko E, Servais A, Hulton SA, Ariceta G, Emma F, Game DS, Lange K, Lapatto R, Liang H, Sberro-Soussan R, Topaloglu R, Das AM, Webb NJA, Wanner C (2022) Expert guidance on the multidisciplinary management of cystinosis in adolescent and adult patients. Clin Kidney J 15:1675\u20131684. https:\/\/doi.org\/10.1093\/ckj\/sfac099","journal-title":"Clin Kidney J"},{"key":"6790_CR92","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10545-011-9281-0","volume":"34","author":"MT Besouw","year":"2011","unstructured":"Besouw MT, Holewijn S, Levtchenko EN, Janssen MC (2011) Non-invasive measurements of atherosclerosis in adult cystinosis patients. J Inherit Metab Dis 34:811\u2013818. https:\/\/doi.org\/10.1007\/s10545-011-9281-0","journal-title":"J Inherit Metab Dis"},{"key":"6790_CR93","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00864385","volume":"7","author":"JL Murphy","year":"1993","unstructured":"Murphy JL, Papathakis PC (1993) Hypercholesterolemia in children with cystinosis. Pediatr Nephrol 7:159\u2013162. https:\/\/doi.org\/10.1007\/BF00864385","journal-title":"Pediatr Nephrol"},{"key":"6790_CR94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ajmg.1320490115","volume":"49","author":"BL Williams","year":"1994","unstructured":"Williams BL, Schneider JA, Trauner DA (1994) Global intellectual deficits in cystinosis. Am J Med Genet 49:83\u201387. https:\/\/doi.org\/10.1002\/ajmg.1320490115","journal-title":"Am J Med Genet"},{"key":"6790_CR95","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1469-8749.1997.tb07455.x","volume":"39","author":"S Colah","year":"1997","unstructured":"Colah S, Trauner DA (1997) Tactile recognition in infantile nephropathic cystinosis. Dev Med Child Neurol 39:409\u2013413. https:\/\/doi.org\/10.1111\/j.1469-8749.1997.tb07455.x","journal-title":"Dev Med Child Neurol"},{"key":"6790_CR96","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2466\/pms.1996.82.1.67","volume":"82","author":"KM Scarvie","year":"1996","unstructured":"Scarvie KM, Ballantyne AO, Trauner DA (1996) Visuomotor performance in children with infantile nephropathic cystinosis. Percept Mot Skills 82:67\u201375. https:\/\/doi.org\/10.2466\/pms.1996.82.1.67","journal-title":"Percept Mot Skills"},{"key":"6790_CR97","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10545-010-9182-7","volume":"33","author":"MT Besouw","year":"2010","unstructured":"Besouw MT, Hulstijn-Dirkmaat GM, van der Rijken RE, Cornelissen EA, van Dael CM, Vande Walle J, Lilien MR, Levtchenko EN (2010) Neurocognitive functioning in school-aged cystinosis patients. J Inherit Metab Dis 33:787\u2013793. https:\/\/doi.org\/10.1007\/s10545-010-9182-7","journal-title":"J Inherit Metab Dis"},{"key":"6790_CR98","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s13023-023-02985-y","volume":"18","author":"DJ Horsthuis","year":"2023","unstructured":"Horsthuis DJ, Molholm S, Foxe JJ, Francisco AA (2023) Event-related potential (ERP) evidence for visual processing differences in children and adults with cystinosis (CTNS gene mutations). Orphanet J Rare Dis 18:389. https:\/\/doi.org\/10.1186\/s13023-023-02985-y","journal-title":"Orphanet J Rare Dis"},{"key":"6790_CR99","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jpeds.2007.02.062","volume":"151","author":"DA Trauner","year":"2007","unstructured":"Trauner DA, Spilkin AM, Williams J, Babchuck L (2007) Specific cognitive deficits in young children with cystinosis: evidence for an early effect of the cystinosin gene on neural function. J Pediatr 151:192\u2013196. https:\/\/doi.org\/10.1016\/j.jpeds.2007.02.062","journal-title":"J Pediatr"},{"key":"6790_CR100","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/WNN.0b013e31828b9f11","volume":"26","author":"AO Ballantyne","year":"2013","unstructured":"Ballantyne AO, Spilkin AM, Trauner DA (2013) Executive function in nephropathic cystinosis. Cogn Behav Neurol 26:14\u201322. https:\/\/doi.org\/10.1097\/WNN.0b013e31828b9f11","journal-title":"Cogn Behav Neurol"},{"key":"6790_CR101","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1017\/s0012162205000782","volume":"47","author":"G Delgado","year":"2005","unstructured":"Delgado G, Schatz A, Nichols S, Appelbaum M, Trauner D (2005) Behavioral profiles of children with infantile nephropathic cystinosis. Dev Med Child Neurol 47:403\u2013407. https:\/\/doi.org\/10.1017\/s0012162205000782","journal-title":"Dev Med Child Neurol"},{"key":"6790_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102170","volume":"25","author":"AA Francisco","year":"2020","unstructured":"Francisco AA, Foxe JJ, Horsthuis DJ, Molholm S (2020) Impaired auditory sensory memory in Cystinosis despite typical sensory processing: a high-density electrical mapping study of the mismatch negativity (MMN). Neuroimage Clin 25:102170. https:\/\/doi.org\/10.1016\/j.nicl.2020.102170","journal-title":"Neuroimage Clin"},{"key":"6790_CR103","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13023-021-01818-0","volume":"16","author":"AA Francisco","year":"2021","unstructured":"Francisco AA, Berruti AS, Kaskel FJ, Foxe JJ, Molholm S (2021) Assessing the integrity of auditory processing and sensory memory in adults with cystinosis (CTNS gene mutations). Orphanet J Rare Dis 16:177. https:\/\/doi.org\/10.1186\/s13023-021-01818-0","journal-title":"Orphanet J Rare Dis"},{"key":"6790_CR104","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13023-019-1271-6","volume":"15","author":"A Curie","year":"2020","unstructured":"Curie A, Touil N, Gaillard S, Galanaud D, Leboucq N, Deschenes G, Morin D, Abad F, Luaute J, Bodenan E, Roche L, Acquaviva C, Vianey-Saban C, Cochat P, Cotton F, Bertholet-Thomas A (2020) Neuropsychological and neuroanatomical phenotype in 17 patients with cystinosis. Orphanet J Rare Dis 15:59. https:\/\/doi.org\/10.1186\/s13023-019-1271-6","journal-title":"Orphanet J Rare Dis"},{"key":"6790_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44162-023-00013-y","volume":"2","author":"D Trauner","year":"2023","unstructured":"Trauner D (2023) Neuro-cognitive complications of nephropathic cystinosis. Journal of Rare Diseases 2:1\u20136. https:\/\/doi.org\/10.1007\/s44162-023-00013-y","journal-title":"Journal of Rare Diseases"},{"key":"6790_CR106","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0887-8994(90)90004-k","volume":"6","author":"SL Nichols","year":"1990","unstructured":"Nichols SL, Press GA, Schneider JA, Trauner DA (1990) Cortical atrophy and cognitive performance in infantile nephropathic cystinosis. Pediatr Neurol 6:379\u2013381. https:\/\/doi.org\/10.1016\/0887-8994(90)90004-k","journal-title":"Pediatr Neurol"},{"key":"6790_CR107","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/0002-9343(87)90661-9","volume":"83","author":"AJ Jonas","year":"1987","unstructured":"Jonas AJ, Conley SB, Marshall R, Johnson RA, Marks M, Rosenberg H (1987) Nephropathic cystinosis with central nervous system involvement. Am J Med 83:966\u2013970. https:\/\/doi.org\/10.1016\/0002-9343(87)90661-9","journal-title":"Am J Med"},{"key":"6790_CR108","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/jimd.12164","volume":"43","author":"A Servais","year":"2020","unstructured":"Servais A, Saitovitch A, Hummel A, Boisgontier J, Scemla A, Sberro-Soussan R, Snanoudj R, Lemaitre H, Legendre C, Pontoizeau C, Antignac C, Anglicheau D, Funalot B, Boddaert N (2020) Central nervous system complications in adult cystinosis patients. J Inherit Metab Dis 43:348\u2013356. https:\/\/doi.org\/10.1002\/jimd.12164","journal-title":"J Inherit Metab Dis"},{"key":"6790_CR109","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF01799350","volume":"19","author":"M Broyer","year":"1996","unstructured":"Broyer M, Tete MJ, Guest G, Bertheleme JP, Labrousse F, Poisson M (1996) Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis 19:65\u201375. https:\/\/doi.org\/10.1007\/BF01799350","journal-title":"J Inherit Metab Dis"},{"key":"6790_CR110","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3928\/01913913-20101217-05","volume":"47","author":"DL Rogers","year":"2010","unstructured":"Rogers DL, McGregor ML (2010) Increased intracranial pressure in patients with cystinosis. J Pediatr Ophthalmol Strabismus 47:e1\u2013e3. https:\/\/doi.org\/10.3928\/01913913-20101217-05","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"6790_CR111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/8904_2016_18","volume":"35","author":"N Martin-Begue","year":"2017","unstructured":"Martin-Begue N, Alarcon S, Wolley-Dod C, Lara LE, Madrid A, Cano P, Del Toro M, Ariceta G (2017) Intracranial hypertension in cystinosis is a challenge: experience in a children\u2019s hospital. JIMD Rep 35:17\u201322. https:\/\/doi.org\/10.1007\/8904_2016_18","journal-title":"JIMD Rep"},{"key":"6790_CR112","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1212\/wnl.32.12.1330","volume":"32","author":"DL Ross","year":"1982","unstructured":"Ross DL, Strife CF, Towbin R, Bove KE (1982) Nonabsorptive hydrocephalus associated with nephropathic cystinosis. Neurology 32:1330\u20131334. https:\/\/doi.org\/10.1212\/wnl.32.12.1330","journal-title":"Neurology"},{"key":"6790_CR113","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/00005072-199011000-00005","volume":"49","author":"DG Vogel","year":"1990","unstructured":"Vogel DG, Malekzadeh MH, Cornford ME, Schneider JA, Shields WD, Vinters HV (1990) Central nervous system involvement in nephropathic cystinosis. J Neuropathol Exp Neurol 49:591\u2013599. https:\/\/doi.org\/10.1097\/00005072-199011000-00005","journal-title":"J Neuropathol Exp Neurol"},{"key":"6790_CR114","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/ndt\/17.10.1766","volume":"17","author":"JM Geelen","year":"2002","unstructured":"Geelen JM, Monnens LA, Levtchenko EN (2002) Follow-up and treatment of adults with cystinosis in the Netherlands. Nephrol Dial Transplant 17:1766\u20131770. https:\/\/doi.org\/10.1093\/ndt\/17.10.1766","journal-title":"Nephrol Dial Transplant"},{"key":"6790_CR115","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cortex.2009.03.008","volume":"46","author":"S Bava","year":"2010","unstructured":"Bava S, Theilmann RJ, Sach M, May SJ, Frank LR, Hesselink JR, Vu D, Trauner DA (2010) Developmental changes in cerebral white matter microstructure in a disorder of lysosomal storage. Cortex 46:206\u2013216. https:\/\/doi.org\/10.1016\/j.cortex.2009.03.008","journal-title":"Cortex"},{"key":"6790_CR116","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/cells11040682","volume":"11","author":"A Servais","year":"2022","unstructured":"Servais A, Boisgontier J, Saitovitch A, Hummel A, Boddaert N (2022) Central nervous system complications in cystinosis: the role of neuroimaging. Cells 11:682. https:\/\/doi.org\/10.3390\/cells11040682","journal-title":"Cells"},{"key":"6790_CR117","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3109\/0886022X.2015.1015391","volume":"37","author":"N Beinart","year":"2015","unstructured":"Beinart N, Hackett RA, Graham CD, Weinman J, Ostermann M (2015) Mood and illness experiences of adults with cystinosis. Ren Fail 37:835\u2013839. https:\/\/doi.org\/10.3109\/0886022X.2015.1015391","journal-title":"Ren Fail"},{"key":"6790_CR118","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jmd2.12352","volume":"64","author":"S Witt","year":"2023","unstructured":"Witt S, Kristensen K, Hohenfellner K, Quitmann J (2023) Health-related quality of life and patient-reported outcome measurements in patients with cystinosis. JIMD Rep 64:199\u2013211. https:\/\/doi.org\/10.1002\/jmd2.12352","journal-title":"JIMD Rep"},{"key":"6790_CR119","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.nefroe.2015.06.010","volume":"35","author":"G Ariceta","year":"2015","unstructured":"Ariceta G, Camacho JA, Fernandez-Obispo M, Fernandez-Polo A, Gamez J, Garcia-Villoria J, Lara Monteczuma E, Leyes P, Martin-Begue N, Oppenheimer F, Perello M, Morell GP, Torra R, Santandreu AV, Guell A, Grupo T-CiS.bcn (2015) Cystinosis in adult and adolescent patients: recommendations for the comprehensive care of cystinosis. Nefrologia 35:304\u2013321. https:\/\/doi.org\/10.1016\/j.nefroe.2015.06.010","journal-title":"Nefrologia"},{"key":"6790_CR120","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s13023-024-03417-1","volume":"19","author":"K Gonzalez","year":"2024","unstructured":"Gonzalez K, Eixarch T, Nunez L, Ariceta G (2024) Quality of life and mental health status in caregivers of pediatric patients with nephropathic cystinosis. Orphanet J Rare Dis 19:415. https:\/\/doi.org\/10.1186\/s13023-024-03417-1","journal-title":"Orphanet J Rare Dis"},{"key":"6790_CR121","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.kint.2021.06.019","volume":"100","author":"F Emma","year":"2021","unstructured":"Emma F, Hoff WV, Hohenfellner K, Topaloglu R, Greco M, Ariceta G, Bettini C, Bockenhauer D, Veys K, Pape L, Hulton S, Collin S, Ozaltin F, Servais A, Deschenes G, Novo R, Bertholet-Thomas A, Oh J, Cornelissen E, Janssen M, Haffner D, Rava L, Antignac C, Devuyst O, Niaudet P, Levtchenko E (2021) An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis. Kidney Int 100:1112\u20131123. https:\/\/doi.org\/10.1016\/j.kint.2021.06.019","journal-title":"Kidney Int"},{"key":"6790_CR122","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00467-010-1641-8","volume":"25","author":"M Greco","year":"2010","unstructured":"Greco M, Brugnara M, Zaffanello M, Taranta A, Pastore A, Emma F (2010) Long-term outcome of nephropathic cystinosis: a 20-year single-center experience. Pediatr Nephrol 25:2459\u20132467. https:\/\/doi.org\/10.1007\/s00467-010-1641-8","journal-title":"Pediatr Nephrol"},{"key":"6790_CR123","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jpeds.2004.03.056","volume":"145","author":"R Kleta","year":"2004","unstructured":"Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA (2004) Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr 145:555\u2013560. https:\/\/doi.org\/10.1016\/j.jpeds.2004.03.056","journal-title":"J Pediatr"},{"key":"6790_CR124","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/BF00868711","volume":"9","author":"WG van\u2019t Hoff","year":"1995","unstructured":"van\u2019t Hoff WG, Gretz N (1995) The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Eire. Pediatr Nephrol 9:685\u2013689. https:\/\/doi.org\/10.1007\/BF00868711","journal-title":"Pediatr Nephrol"},{"key":"6790_CR125","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ymgme.2012.06.017","volume":"107","author":"M Besouw","year":"2012","unstructured":"Besouw M, Tangerman A, Cornelissen E, Rioux P, Levtchenko E (2012) Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate. Mol Genet Metab 107:234\u2013236. https:\/\/doi.org\/10.1016\/j.ymgme.2012.06.017","journal-title":"Mol Genet Metab"},{"key":"6790_CR126","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ymgme.2007.04.002","volume":"91","author":"M Besouw","year":"2007","unstructured":"Besouw M, Blom H, Tangerman A, de Graaf-Hess A, Levtchenko E (2007) The origin of halitosis in cystinotic patients due to cysteamine treatment. Mol Genet Metab 91:228\u2013233. https:\/\/doi.org\/10.1016\/j.ymgme.2007.04.002","journal-title":"Mol Genet Metab"},{"key":"6790_CR127","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jpeds.2011.05.057","volume":"159","author":"MT Besouw","year":"2011","unstructured":"Besouw MT, Bowker R, Dutertre JP, Emma F, Gahl WA, Greco M, Lilien MR, McKiernan J, Nobili F, Schneider JA, Skovby F, van den Heuvel LP, Van\u2019t Hoff WG, Levtchenko EN (2011) Cysteamine toxicity in patients with cystinosis. J Pediatr 159:1004\u20131011. https:\/\/doi.org\/10.1016\/j.jpeds.2011.05.057","journal-title":"J Pediatr"},{"key":"6790_CR128","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00467-005-2052-0","volume":"21","author":"EN Levtchenko","year":"2006","unstructured":"Levtchenko EN, van Dael CM, de Graaf-Hess AC, Wilmer MJ, van den Heuvel LP, Monnens LA, Blom HJ (2006) Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis. Pediatr Nephrol 21:110\u2013113. https:\/\/doi.org\/10.1007\/s00467-005-2052-0","journal-title":"Pediatr Nephrol"},{"key":"6790_CR129","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1001\/jama.1993.03510180070036","volume":"270","author":"DS Theodoropoulos","year":"1993","unstructured":"Theodoropoulos DS, Krasnewich D, Kaiser-Kupfer MI, Gahl WA (1993) Classic nephropathic cystinosis as an adult disease. JAMA 270:2200\u20132204","journal-title":"JAMA"},{"key":"6790_CR130","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00467-012-2315-5","volume":"28","author":"R Dohil","year":"2013","unstructured":"Dohil R, Cabrera BL (2013) Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up. Pediatr Nephrol 28:507\u2013510. https:\/\/doi.org\/10.1007\/s00467-012-2315-5","journal-title":"Pediatr Nephrol"},{"key":"6790_CR131","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.2215\/CJN.12321211","volume":"7","author":"CB Langman","year":"2012","unstructured":"Langman CB, Greenbaum LA, Sarwal M, Grimm P, Niaudet P, Deschenes G, Cornelissen E, Morin D, Cochat P, Matossian D, Gaillard S, Bagger MJ, Rioux P (2012) A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety. Clin J Am Soc Nephrol 7:1112\u20131120. https:\/\/doi.org\/10.2215\/CJN.12321211","journal-title":"Clin J Am Soc Nephrol"},{"key":"6790_CR132","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jpeds.2014.05.013","volume":"165","author":"CB Langman","year":"2014","unstructured":"Langman CB, Greenbaum LA, Grimm P, Sarwal M, Niaudet P, Deschenes G, Cornelissen EA, Morin D, Cochat P, Elenberg E, Hanna C, Gaillard S, Bagger MJ, Rioux P (2014) Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate. J Pediatr 165:528\u2013533. https:\/\/doi.org\/10.1016\/j.jpeds.2014.05.013","journal-title":"J Pediatr"},{"key":"6790_CR133","first-page":"71","volume":"22","author":"T Morrow","year":"2013","unstructured":"Morrow T (2013) Do comparable efficacy & convenient dosing justify Procysbi\u2019s extremely high price? Manag Care 22:71\u201372","journal-title":"Manag Care"},{"key":"6790_CR134","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ymgme.2022.06.010","volume":"136","author":"C Niessl","year":"2022","unstructured":"Niessl C, Boulesteix AL, Oh J, Palm K, Schlingmann P, Wygoda S, Haffner D, Wuhl E, Tonshoff B, Buescher A, Billing H, Hoppe B, Zirngibl M, Kettwig M, Moeller K, Acham-Roschitz B, Arbeiter K, Bald M, Benz M, Galiano M, John-Kroegel U, Klaus G, Marx-Berger D, Moser K, Mueller D, Patzer L, Pohl M, Seitz B, Treikauskas U, von Vigier RO, Gahl WA, Hohenfellner K (2022) Relationship between age at initiation of cysteamine treatment, adherence with therapy, and glomerular kidney function in infantile nephropathic cystinosis. Mol Genet Metab 136:268\u2013273. https:\/\/doi.org\/10.1016\/j.ymgme.2022.06.010","journal-title":"Mol Genet Metab"},{"key":"6790_CR135","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00467-014-3018-x","volume":"30","author":"G Nesterova","year":"2015","unstructured":"Nesterova G, Williams C, Bernardini I, Gahl WA (2015) Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy. Pediatr Nephrol 30:945\u2013951. https:\/\/doi.org\/10.1007\/s00467-014-3018-x","journal-title":"Pediatr Nephrol"},{"key":"6790_CR136","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ymgme.2022.06.009","volume":"136","author":"K Hohenfellner","year":"2022","unstructured":"Hohenfellner K, Niessl C, Haffner D, Oh J, Okorn C, Palm K, Schlingmann KP, Wygoda S, Gahl WA (2022) Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis. Mol Genet Metab 136:282\u2013288. https:\/\/doi.org\/10.1016\/j.ymgme.2022.06.009","journal-title":"Mol Genet Metab"},{"issue":"Pt 6","key":"6790_CR137","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/eye.1991.139","volume":"5","author":"JA Bradbury","year":"1991","unstructured":"Bradbury JA, Danjoux JP, Voller J, Spencer M, Brocklebank T (1991) A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis. Eye (Lond) 5(Pt 6):755\u2013760. https:\/\/doi.org\/10.1038\/eye.1991.139","journal-title":"Eye (Lond)"},{"key":"6790_CR138","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/bjophthalmol-2016-309278","volume":"101","author":"A Al-Hemidan","year":"2017","unstructured":"Al-Hemidan A, Shoughy SS, Kozak I, Tabbara KF (2017) Efficacy of topical cysteamine in nephropathic cystinosis. Br J Ophthalmol 101:1234\u20131237. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309278","journal-title":"Br J Ophthalmol"},{"key":"6790_CR139","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40123-019-00216-x","volume":"8","author":"F Peeters","year":"2019","unstructured":"Peeters F, Cassiman C, Van Keer K, Levtchenko E, Veys K, Casteels I (2019) Ophthalmic outcome in a Belgian cohort of cystinosis patients treated with a compounded preparation of cysteamine eye drops: retrospective analysis. Ophthalmol Ther 8:623\u2013633. https:\/\/doi.org\/10.1007\/s40123-019-00216-x","journal-title":"Ophthalmol Ther"},{"key":"6790_CR140","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1167\/iovs.16-21080","volume":"58","author":"H Liang","year":"2017","unstructured":"Liang H, Labbe A, Le Mouhaer J, Plisson C, Baudouin C (2017) A new viscous cysteamine eye drops treatment for ophthalmic cystinosis: an open-label randomized comparative phase III pivotal study. Invest Ophthalmol Vis Sci 58:2275\u20132283. https:\/\/doi.org\/10.1167\/iovs.16-21080","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6790_CR141","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1021\/acs.molpharmaceut.6b00488","volume":"13","author":"DC Marcano","year":"2016","unstructured":"Marcano DC, Shin CS, Lee B, Isenhart LC, Liu X, Li F, Jester JV, Pflugfelder SC, Simpson J, Acharya G (2016) Synergistic cysteamine delivery nanowafer as an efficacious treatment modality for corneal cystinosis. Mol Pharm 13:3468\u20133477. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00488","journal-title":"Mol Pharm"},{"key":"6790_CR142","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1007\/s13346-020-00890-6","volume":"11","author":"J Jimenez","year":"2021","unstructured":"Jimenez J, Washington MA, Resnick JL, Nischal KK, Fedorchak MV (2021) A sustained release cysteamine microsphere\/thermoresponsive gel eyedrop for corneal cystinosis improves drug stability. Drug Deliv Transl Res 11:2224\u20132238. https:\/\/doi.org\/10.1007\/s13346-020-00890-6","journal-title":"Drug Deliv Transl Res"},{"key":"6790_CR143","doi-asserted-by":"publisher","first-page":"100514","DOI":"10.1016\/j.ymgmr.2019.100514","volume":"21","author":"K Hohenfellner","year":"2019","unstructured":"Hohenfellner K, Bergmann C, Fleige T, Janzen N, Burggraf S, Olgemoller B, Gahl WA, Czibere L, Froschauer S, Roschinger W, Vill K, Harms E, Nennstiel U (2019) Molecular based newborn screening in Germany: follow-up for cystinosis. Mol Genet Metab Rep 21:100514. https:\/\/doi.org\/10.1016\/j.ymgmr.2019.100514","journal-title":"Mol Genet Metab Rep"},{"key":"6790_CR144","doi-asserted-by":"publisher","first-page":"F905","DOI":"10.1152\/ajprenal.00318.2010","volume":"299","author":"MJ Wilmer","year":"2010","unstructured":"Wilmer MJ, Emma F, Levtchenko EN (2010) The pathogenesis of cystinosis: mechanisms beyond cystine accumulation. Am J Physiol Renal Physiol 299:F905-916. https:\/\/doi.org\/10.1152\/ajprenal.00318.2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"6790_CR145","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrneph.2016.182","volume":"13","author":"S Cherqui","year":"2017","unstructured":"Cherqui S, Courtoy PJ (2017) The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives. Nat Rev Nephrol 13:115\u2013131. https:\/\/doi.org\/10.1038\/nrneph.2016.182","journal-title":"Nat Rev Nephrol"},{"key":"6790_CR146","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.molmed.2021.04.004","volume":"27","author":"A Jamalpoor","year":"2021","unstructured":"Jamalpoor A, Othman A, Levtchenko EN, Masereeuw R, Janssen MJ (2021) Molecular mechanisms and treatment options of nephropathic cystinosis. Trends Mol Med 27:673\u2013686. https:\/\/doi.org\/10.1016\/j.molmed.2021.04.004","journal-title":"Trends Mol Med"},{"key":"6790_CR147","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cells11020190","volume":"11","author":"MA Elmonem","year":"2022","unstructured":"Elmonem MA, Veys KRP, Prencipe G (2022) Nephropathic cystinosis: pathogenic roles of inflammation and potential for new therapies. Cells 11:190. https:\/\/doi.org\/10.3390\/cells11020190","journal-title":"Cells"},{"key":"6790_CR148","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.kint.2015.12.045","volume":"89","author":"LR Rega","year":"2016","unstructured":"Rega LR, Polishchuk E, Montefusco S, Napolitano G, Tozzi G, Zhang J, Bellomo F, Taranta A, Pastore A, Polishchuk R, Piemonte F, Medina DL, Catz SD, Ballabio A, Emma F (2016) Activation of the transcription factor EB rescues lysosomal abnormalities in cystinotic kidney cells. Kidney Int 89:862\u2013873. https:\/\/doi.org\/10.1016\/j.kint.2015.12.045","journal-title":"Kidney Int"},{"key":"6790_CR149","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/hmg\/ddac266","volume":"32","author":"E De Leo","year":"2023","unstructured":"De Leo E, Taranta A, Raso R, Polishchuk E, D\u2019Oria V, Pezzullo M, Goffredo BM, Cairoli S, Bellomo F, Battafarano G, Camassei FD, Del Fattore A, Polishchuk R, Emma F, Rega LR (2023) Genistein improves renal disease in a mouse model of nephropathic cystinosis: a comparison study with cysteamine. Hum Mol Genet 32:1090\u20131101. https:\/\/doi.org\/10.1093\/hmg\/ddac266","journal-title":"Hum Mol Genet"},{"key":"6790_CR150","doi-asserted-by":"publisher","first-page":"e13067","DOI":"10.15252\/emmm.202013067","volume":"13","author":"A Jamalpoor","year":"2021","unstructured":"Jamalpoor A, van Gelder CA, Yousef Yengej FA, Zaal EA, Berlingerio SP, Veys KR, Pou Casellas C, Voskuil K, Essa K, Ammerlaan CM, Rega LR, van der Welle RE, Lilien MR, Rookmaaker MB, Clevers H, Klumperman J, Levtchenko E, Berkers CR, Verhaar MC, Altelaar M, Masereeuw R, Janssen MJ (2021) Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis. EMBO Mol Med 13:e13067. https:\/\/doi.org\/10.15252\/emmm.202013067","journal-title":"EMBO Mol Med"},{"key":"6790_CR151","doi-asserted-by":"publisher","first-page":"12829","DOI":"10.3390\/ijms222312829","volume":"22","author":"F Bellomo","year":"2021","unstructured":"Bellomo F, De Leo E, Taranta A, Giaquinto L, Di Giovamberardino G, Montefusco S, Rega LR, Pastore A, Medina DL, Di Bernardo D, De Matteis MA, Emma F (2021) Drug repurposing in rare diseases: an integrative study of drug screening and transcriptomic analysis in nephropathic cystinosis. Int J Mol Sci 22:12829. https:\/\/doi.org\/10.3390\/ijms222312829","journal-title":"Int J Mol Sci"},{"key":"6790_CR152","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1681\/ASN.2019090956","volume":"31","author":"E De Leo","year":"2020","unstructured":"De Leo E, Elmonem MA, Berlingerio SP, Berquez M, Festa BP, Raso R, Bellomo F, Starborg T, Janssen MJ, Abbaszadeh Z, Cairoli S, Goffredo BM, Masereeuw R, Devuyst O, Lowe M, Levtchenko E, Luciani A, Emma F, Rega LR (2020) Cell-based phenotypic drug screening identifies luteolin as candidate therapeutic for nephropathic cystinosis. J Am Soc Nephrol 31:1522\u20131537. https:\/\/doi.org\/10.1681\/ASN.2019090956","journal-title":"J Am Soc Nephrol"},{"key":"6790_CR153","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.3390\/cells10123294","volume":"10","author":"A Taranta","year":"2021","unstructured":"Taranta A, Elmonem MA, Bellomo F, De Leo E, Boenzi S, Janssen MJ, Jamalpoor A, Cairoli S, Pastore A, De Stefanis C, Colucci M, Rega LR, Giovannoni I, Francalanci P, van den Heuvel LP, Dionisi-Vici C, Goffredo BM, Masereeuw R, Levtchenko E, Emma F (2021) Benefits and toxicity of disulfiram in preclinical models of nephropathic cystinosis. Cells 10:3294. https:\/\/doi.org\/10.3390\/cells10123294","journal-title":"Cells"},{"key":"6790_CR154","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00467-018-4094-0","volume":"34","author":"EJ Brasell","year":"2019","unstructured":"Brasell EJ, Chu L, El Kares R, Seo JH, Loesch R, Iglesias DM, Goodyer P (2019) The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis. Pediatr Nephrol 34:873\u2013881. https:\/\/doi.org\/10.1007\/s00467-018-4094-0","journal-title":"Pediatr Nephrol"},{"key":"6790_CR155","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/pr.2016.184","volume":"81","author":"A Taranta","year":"2017","unstructured":"Taranta A, Bellomo F, Petrini S, Polishchuk E, De Leo E, Rega LR, Pastore A, Polishchuk R, De Matteis MA, Emma F (2017) Cystinosin-LKG rescues cystine accumulation and decreases apoptosis rate in cystinotic proximal tubular epithelial cells. Pediatr Res 81:113\u2013119. https:\/\/doi.org\/10.1038\/pr.2016.184","journal-title":"Pediatr Res"},{"key":"6790_CR156","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/jcph.1807","volume":"61","author":"T Haverty","year":"2021","unstructured":"Haverty T, Wyatt DJ, Porter KM, Leubitz A, Banks K, Goodyer P, Hu MY (2021) Phase 1 renal impairment trial results supports targeted individualized dosing of ELX-02 in patients with nephropathic cystinosis. J Clin Pharmacol 61:923\u2013931. https:\/\/doi.org\/10.1002\/jcph.1807","journal-title":"J Clin Pharmacol"},{"key":"6790_CR157","doi-asserted-by":"publisher","first-page":"20961","DOI":"10.1038\/s41598-023-47085-w","volume":"13","author":"T Bondue","year":"2023","unstructured":"Bondue T, Berlingerio SP, Siegerist F, Sendino-Garvi E, Schindler M, Baelde HJ, Cairoli S, Goffredo BM, Arcolino FO, Dieker J, Janssen MJ, Endlich N, Brock R, Gijsbers R, van den Heuvel L, Levtchenko E (2023) Evaluation of the efficacy of cystinosin supplementation through CTNS mRNA delivery in experimental models for cystinosis. Sci Rep 13:20961. https:\/\/doi.org\/10.1038\/s41598-023-47085-w","journal-title":"Sci Rep"},{"key":"6790_CR158","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.3390\/cells10123273","volume":"10","author":"S Cherqui","year":"2021","unstructured":"Cherqui S (2021) Hematopoietic stem cell gene therapy for cystinosis: from bench-to-bedside. Cells 10:3273. https:\/\/doi.org\/10.3390\/cells10123273","journal-title":"Cells"},{"key":"6790_CR159","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1056\/NEJMc1309480","volume":"370","author":"A Bertholet-Thomas","year":"2014","unstructured":"Bertholet-Thomas A, Bacchetta J, Tasic V, Cochat P (2014) Nephropathic cystinosis\u2014a gap between developing and developed nations. N Engl J Med 370:1366\u20131367. https:\/\/doi.org\/10.1056\/NEJMc1309480","journal-title":"N Engl J Med"},{"key":"6790_CR160","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00467-023-06179-3","volume":"39","author":"M Regnier","year":"2024","unstructured":"Regnier M, Flammier S, Boutaba M, Ndongo AA, Servais A, Schaefer F, Levtchenko E, Bacchetta J, Bertholet-Thomas A (2024) Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective. Pediatr Nephrol 39:1113\u20131123. https:\/\/doi.org\/10.1007\/s00467-023-06179-3","journal-title":"Pediatr Nephrol"},{"key":"6790_CR161","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13023-021-01923-0","volume":"16","author":"WA Gahl","year":"2021","unstructured":"Gahl WA, Wong-Rieger D, Hivert V, Yang R, Zanello G, Groft S (2021) Essential list of medicinal products for rare diseases: recommendations from the IRDiRC Rare Disease Treatment Access Working Group. Orphanet J Rare Dis 16:308. https:\/\/doi.org\/10.1186\/s13023-021-01923-0","journal-title":"Orphanet J Rare Dis"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06790-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T20:02:26Z","timestamp":1766520146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06790-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":161,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["6790"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06790-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the Institutional Review Board of the National Human Genome Research Institute and adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patients and\/or their families.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}